In a tauP301L mouse model of Alzheimer’s disease, Au-PEG treatment reduced circulating tau levels in the serum, suggesting its potential to limit tau propagation to neighboring neurons and other CNS cells. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.